European Patent Office

T 3122/19 (FGFR3 fusion gene/CHUGAI SEIYAKU KABUSHIKI) of 14.09.2023

European Case Law Identifier
ECLI:EP:BA:2023:T312219.20230914
Date of decision
14 September 2023
Case number
T 3122/19
Petition for review of
-
Application number
13842962.6
Language of proceedings
English
Distribution
No distribution (D)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
-
Application title
FGFR3 fusion gene and pharmaceutical drug targeting same
Applicant name
Chugai Seiyaku Kabushiki Kaisha
Opponent name
Murphy, Colm Damien
Board
3.3.04
Headnote
-
Relevant legal provisions
European Patent Convention Art 123(2)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 83European Patent Convention Art 89Rules of procedure of the Boards of Appeal 2020 Art 012(4)Rules of procedure of the Boards of Appeal 2020 Art 012(6)Rules of procedure of the Boards of Appeal 2020 Art 013(2)
Keywords
Main request - novelty (no)
Auxiliary request 1 - priority, inventive step (no)
Auxiliary request 2 - added matter (no), priority, novelty, inventive step, sufficiency of disclosure (yes)
Late-filed evidence - admitted in first-instance proceedings (no)
Late-filed evidence - should have been submitted in first-instance proceedings (yes)
Amendment after summons - cogent reasons (no)
Catchword
-
Citing cases
-

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the opposition division with the order to maintain the patent in amended form according to the claims of auxiliary request 2, filed as auxiliary request 4 with the patent proprietor's statement setting out the grounds of appeal, and a description and drawings possibly adapted thereto.